10x Genomics
10x Genomics raises $55M Series E at $500M valuation
Quick Facts
10x Genomics: Series E Funding Round
10x Genomics has successfully raised $55M in Series E funding, reaching a valuation of $500M.
Company Overview
Single-cell genomics and spatial biology
Funding Details
The Series E round was led by Softbank Vision Fund, with participation from Fidelity.
Company Information
- Headquarters: Pleasanton, CA
- Founded: 2012
- Employees: 800+
- Category: Biotech
Investment
10x Genomics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Softbank Vision Fund: Verified investor in Series E
- Fidelity: Verified investor in Series E
Key Investors
About the Author
Related Company Reports
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
